Damir Vrbanec
Juraj Dobrila University of Pula(HR)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Neuroendocrine Tumor Research Advances, Estrogen and related hormone effects
Most-Cited Works
- → Delays in diagnosis and treatment of breast cancer: a multinational analysis(2013)146 cited
- → Single-Nucleotide Polymorphisms in Genes Encoding Toll-Like Receptor -2, -3, -4, and -9 in Case–Control Study with Breast Cancer(2009)53 cited
- → A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries(2020)43 cited
- → Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype(2016)29 cited
- → FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study(2014)29 cited
- → Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer(2015)24 cited
- → Prognostic Value of Different Factors in Breast Carcinoma(2004)22 cited
- → CL097, A TLR7/8 LIGAND, INHIBITS TLR-4-DEPENDENT ACTIVATION OF IRAK-M AND BCL-3 EXPRESSION(2009)21 cited
- → Nm23 Gene Product Expression in Invasive Breast Cancer(2002)21 cited
- → Prognostic value of proliferation markers expression in breast cancer(2013)19 cited